UTI AMC nosedives ~8% as PAT sinks over 60% for Q4FY22

27 Apr 2022 , 03:01 PM

UTI AMC Limited has announced its financial results for the quarter and year ended March 31, 2022.

The company’s Revenue from Operations for FY22 was reported at Rs1,319 crore, up by 13% yoy from FY21. The Core Revenue from Operations for FY22, consisting of Sale of Services, amounted to Rs1,119 crore up by 39% yoy as compared to FY 21.

Revenue from Operations for the January-March quarter reported at Rs301 crore up by 4% yoy against previous corresponding quarter. PBT for the fourth quarter of FY22 was at Rs97 crore, down by 36% yoy against Q4FY21.

UTI’s PBT for FY22 stood at Rs660 crore, up by 9% yoy as compared to FY 21. The Core PBT for FY22 (excluding M2M Gains, Income from Sale of Investments, and other Non-operating Income) was reported at Rs452 crore, up by 91% against FY21.

Profit After Tax for FY22 stood at Rs534 crore, up by 8% against FY21. PAT for Q4FY22 stood at Rs54 crore, a decline of 60% yoy against the previous corresponding quarter.

The Board recommended a final dividend of Rs21 per share for FY22 as against Rs17 per share in FY21.

Total AUM for UTI AMC was reported at Rs13,48,905 crore.

UTI AMC is currently trading at Rs860.30 down by Rs67.85 or 7.31% from its previous closing of Rs928.15 on the BSE. It has touched intraday high and low of Rs894.75 and Rs844.30 respectively so far.